Identification of different shapes, colors and sizes of standard oral dosage forms in diabetes type 2 patients – a pilot study

Sven Stegemann*, Regina Riedl, Harald Sourij

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

The clear identification of drug products by the patients is essential for a safe and effective medication management. In order to understand the impact of shape, size and color on medication identification a study was performed in subjects with type 2 diabetes mellitus (T2D). Ten model drugs differentiated by shape, size and color were evaluated using a mixed method of medication schedule preparation by the participants followed by a semi-structured interview. Detection times were fastest for the large round tablet shape and the bi-chromatic forms. Larger size was easier to identify than the smaller sizes except for the bi-chromatic forms. The shape was the major source of errors, followed by the size and the color dimension. The results from this study suggests that color as a single dimension are perceived more effectively by subjects with T2D compared to shape and size, which requires a more demanding processing of three dimension and is dependent on the perspective.
Original languageEnglish
Pages (from-to)112-118
Number of pages118
JournalInternational Journal of Pharmaceutics
Volume517
DOIs
Publication statusPublished - 1 Jan 2017

Keywords

  • Drug identification
  • medicine design

Fields of Expertise

  • Human- & Biotechnology

Treatment code (Nähere Zuordnung)

  • Experimental

Cooperations

  • BioTechMed-Graz

Fingerprint

Dive into the research topics of 'Identification of different shapes, colors and sizes of standard oral dosage forms in diabetes type 2 patients – a pilot study'. Together they form a unique fingerprint.

Cite this